...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: MOA of Apabetalone - only affects sick patients

Bear

if there are some patients in BOM on sglt2 inhibitors it might be interesting to see if those also on 208 show any synergies in a sub group analysis ? IF they do then perhaps there would be good rational for combination with sglt2i’s? Has the Company filed any Patents in this space ?

Thanks in advance !

 

 

 

Share
New Message
Please login to post a reply